These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 27838536

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A comparison between vaginal estrogen and vaginal hyaluronic for the treatment of dyspareunia in women using hormonal contraceptive.
    Serati M, Bogani G, Di Dedda MC, Braghiroli A, Uccella S, Cromi A, Ghezzi F.
    Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():48-50. PubMed ID: 26070127
    [Abstract] [Full Text] [Related]

  • 6. Local ultra-low-dose estriol gel treatment of vulvo-vaginal atrophy: efficacy and safety of long-term treatment.
    Villa P, Tagliaferri V, Amar ID, Cipolla C, Ingravalle F, Scambia G, Ricciardi W, Lanzone A.
    Gynecol Endocrinol; 2020 Jun; 36(6):535-539. PubMed ID: 31847628
    [Abstract] [Full Text] [Related]

  • 7. Is vaginal hyaluronic acid as effective as vaginal estriol for vaginal dryness relief?
    Stute P.
    Arch Gynecol Obstet; 2013 Dec; 288(6):1199-201. PubMed ID: 24178484
    [Abstract] [Full Text] [Related]

  • 8. Quality of life and sexual function of naturally postmenopausal women on an ultralow-concentration estriol vaginal gel.
    Caruso S, Cianci S, Amore FF, Ventura B, Bambili E, Spadola S, Cianci A.
    Menopause; 2016 Jan; 23(1):47-54. PubMed ID: 26079974
    [Abstract] [Full Text] [Related]

  • 9. A randomized, multicenter, double-blind study to evaluate the safety and efficacy of estradiol vaginal cream 0.003% in postmenopausal women with dyspareunia as the most bothersome symptom.
    Kroll R, Archer DF, Lin Y, Sniukiene V, Liu JH.
    Menopause; 2018 Feb; 25(2):133-138. PubMed ID: 28926514
    [Abstract] [Full Text] [Related]

  • 10. The REJOICE trial: a phase 3 randomized, controlled trial evaluating the safety and efficacy of a novel vaginal estradiol soft-gel capsule for symptomatic vulvar and vaginal atrophy.
    Constantine GD, Simon JA, Pickar JH, Archer DF, Kushner H, Bernick B, Gasper G, Graham S, Mirkin S, REJOICE Study Group.
    Menopause; 2017 Apr; 24(4):409-416. PubMed ID: 27922936
    [Abstract] [Full Text] [Related]

  • 11. Effectiveness of Combination of Tibolone and Lactobacilli Plus Lactoferrin in Postmenopausal Women with Vulvar Vestibular Pain: A Preliminary Report.
    De Leo V, Governini L, Ponchia R, Recalcati D, Murina F.
    Nutrients; 2024 Jul 22; 16(14):. PubMed ID: 39064821
    [Abstract] [Full Text] [Related]

  • 12. Vulvovaginal Issues in Mature Women.
    Marnach ML, Torgerson RR.
    Mayo Clin Proc; 2017 Mar 22; 92(3):449-454. PubMed ID: 28259230
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics and preliminary efficacy of two vaginal gel formulations of ultra-low-dose estriol in postmenopausal women.
    Delgado JL, Estevez J, Radicioni M, Loprete L, Moscoso Del Prado J, Nieto Magro C.
    Climacteric; 2016 Apr 22; 19(2):172-80. PubMed ID: 26786399
    [Abstract] [Full Text] [Related]

  • 14. Vaginal hormone-free moisturising cream is not inferior to an estriol cream for treating symptoms of vulvovaginal atrophy: Prospective, randomised study.
    Garcia de Arriba S, Grüntkemeier L, Häuser M, May TW, Masur C, Stute P.
    PLoS One; 2022 Apr 22; 17(5):e0266633. PubMed ID: 35551533
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Treatment of Secondary Vestibulodynia with Conjugated Estrogen Cream: A Pilot, Double-Blind, Randomized Placebo-Controlled Trial.
    Langlais EL, Lefebvre J, Maheux-Lacroix S, Bujold E, Fortier M, Bouchard C.
    J Obstet Gynaecol Can; 2017 Jun 22; 39(6):453-458. PubMed ID: 28342741
    [Abstract] [Full Text] [Related]

  • 19. Effects of ultralow topical estriol dose on vaginal health and quality of life in postmenopausal women who underwent surgical treatment for pelvic organ prolapse.
    Caruso S, Cianci S, Vitale SG, Matarazzo MG, Amore FF, Cianci A.
    Menopause; 2017 Aug 22; 24(8):900-907. PubMed ID: 28350758
    [Abstract] [Full Text] [Related]

  • 20. Low-dose vaginal estrogens or vaginal moisturizer in breast cancer survivors with urogenital atrophy: a preliminary study.
    Biglia N, Peano E, Sgandurra P, Moggio G, Panuccio E, Migliardi M, Ravarino N, Ponzone R, Sismondi P.
    Gynecol Endocrinol; 2010 Jun 22; 26(6):404-12. PubMed ID: 20196634
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.